PET Scans For Decision-Making In Metastatic Renal Cell Carcinoma: A Single-Institution Evaluation

... UroToday.com- While PET scans with flourodeoxyglucose have been embraced as a staging tool in a wide variety of oncologic subspecialties, the role of PET scanning in directing the therapy of patients with metastatic renal cell carcinoma (mRCC) remains unclear. Here, Dilhuydy and colleagues examine their limited experience with this imaging modality in directing therapy for patients with mRCC. [click link for full article] ...